Print

Banner Pharmacaps Inc. and JDS Pharmaceuticals Announce License and Supply Agreement  
5/30/2007 2:59:27 PM

HIGH POINT, N.C.--(BUSINESS WIRE)--Banner Pharmacaps Inc. and JDS Pharmaceuticals LLC announced today that they have entered into an agreement for JDS to commercialize Banner’s novel softgel formulation of Valproic Acid. Banner’s New Drug Application for Valproic Acid Delayed Release, based on its patent-pending EnteriCare™ technology, was accepted by the FDA on February 20, 2007, with approval anticipated in October, 2007. Product launch is planned for the first quarter of 2008. Terms of the agreement between the two privately-held companies were not released.
//-->